Biostar Pharmaceuticals, Inc. Supplements Its FYE 2009 Results and Provides Fourth Quarter Results
XIANYANG, China, April 5 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), the Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsule ("Xin Aoxing"), and other pharma...
Biostar Pharmaceuticals, Inc. Reports Fiscal 2009 Financial Results
Company Increases 2010 Revenue Guidance to $80 million-$82 million and Net Income to $18 million-$20 million XIANYANG, China, April 1 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), the Xianyang-based manufacturer of a leading ov...
Earnings Conference Call Schedule Change Notification: Biostar Pharmaceuticals, Inc. to Host Fiscal 2009 Year End Earnings Conference Call on Thursday, April 1, 2010 at 10:00 a.m. ET
XIANYANG, China, March 31 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), the Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsule ("Xin Aoxing"), and a variety of p...
Biostar Pharmaceuticals, Inc. to Host Fiscal 2009 Fourth Quarter and Year End Earnings Conference Call on Friday, April 2, 2010 at 9:00 a.m. ET
XIANYANG, China, March 29 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), the Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsule ("Xin Aoxing"), and a variety of pharmaceuti...
Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing
XIANYANG, China, March 3 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), the Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsule ("Xin Aoxing"), and a variety of pharmaceutic...
Biostar Pharmaceuticals, Inc. Announces 2010 Guidance: Revenues of $69 to $71 Million and Net Income $16.2 to $17 Million
XIANYANG, China, March 1 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), the Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsule ("Xin Aoxing"), and a variety of pharmaceutic...
Biostar Pharmaceuticals, Inc. Provides Preliminary 2009 Results: Revenue of $52 - $54 Million and Operating Income of $16 - $17 Million Excluding Non-cash Charges
XIANYANG, China, Feb. 25 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today annou...
Biostar Pharmaceuticals, Inc. Announces Change of Auditor
XIANYANG, China, Jan. 28 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today annou...
Biostar Pharmaceuticals Strengthens Corporate Governance with Appointments of New Independent Directors, Establishment of Board Committees and Adoption of Code of Ethics
XI'AN, China, Jan. 4 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced...
Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai
Management anticipates $9 million in 2010 revenues from this initiative XIANYANG, China, Dec. 29 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and...
Biostar Pharmaceuticals, Inc. Secures Letter of Intent to Acquire Xi'an-Based Medical Equipment and Nutrients Manufacturer
Potential acquisition will expand product portfolio and Introduces Medical Devices to BioStar's Distribution Network XIANYANG, China, Dec. 16 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufactur...
Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
-- Q3 2009 revenue increased 106.3% to $15.6 million; Q3 Gross Margins of 77.0% -- Q3 2009 net income increased 459.2% to $3.1 million with EPS of $0.13 -- Revenue for the first nine months increased 52.5 % to $36.2 million; net income increased 112.9% to $8.8 m...
Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Third Quarter Earnings Conference Call on Thursday, November 12, 2009 at 9:30 a.m. ET
XIANYANG, China, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions...
Biostar Pharmaceuticals Announces Closing of a $3.6 Million Equity Financing
XIANYANG, China, Nov. 6 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions,...
Biostar Pharmaceuticals, Inc. to Present at the Brean Murray, Carret & Co. China Growth Conference
XIANYANG, China, Nov. 4 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions...
Biostar Pharmaceuticals, Inc. Significantly Increases Rural Supply Network to 3,500 Sales Outlets
XIANYANG, China, Nov. 3 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announ...
Biostar Pharmaceuticals, Inc. Receives Patent for Aoxing Ganbao
XIANYANG, China, Oct. 2 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, ...
Biostar Pharmaceuticals, Inc. to Present at the Maxim Group Growth Conference on September 29 at 2:00pm ET
XIANYANG, China, Sept. 22 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today anno...
Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
Second Quarter 2009 Revenue Increased 40.6% to Approximately $13.2 Million and Net Income Increased 119.3% to Approximately $3.9 Million with EPS of $0.17 Gross Margins Improved 1630-Basis Points to 73.5% over Q2 2008 XIANYANG, China, Aug. 14 /PRNewswire-Asia-FirstCall/ -- Biostar Pharma...
Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
XIANYANG, China, Aug. 12 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today annou...
